BeStock  
Stocks › Biotechnology › DBVT

DBV Technologies DBVT

US equityMarket cap rank #3606Biotechnology
$9.77 −$0.21 (-2.10%)
Pre-market · Oct 8, 9:00 am ET · After hours $9.32 -4.61%
Open$9.74
Prev close$9.98
Day range$9.64 – $10.05
Volume535.3K
Market cap$614.03M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$50.60M-22.8% YoY
Net profit-$50.40M-20.3% YoY
Diluted EPS-$0.60+61.3% YoY
Free cash flow-$53.00M-56.3% YoY
Operating cash flow-$52.60M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-30.4MSep '24$-23.0MDec '24$-27.1MMar '25$-41.9MJun '25$-33.2MSep '25$-44.8MDec '25$-47.6MMar '26$-50.4MJun '26

Diluted EPS by quarter

-1.60Sep '24-1.10Dec '24-1.30Mar '25-1.55Jun '25-1.20Sep '25-1.15Dec '25-0.55Mar '26-0.60Jun '26

Free cash flow by quarter

$-22.9MSep '24$-12.1MDec '24$-19.7MMar '25$-33.9MJun '25$-32.6MSep '25$-35.6MDec '25$-49.5MMar '26$-53.0MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-142.6%
Return on assets-96.0%
Return on invested capital-134.3%
Current ratio3.72
Liabilities / assets28.1%
Cash & investments$174.90M
Total debt$6.90M
Net cash (debt)$168.00M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $50.60M $47.90M $147.05M $45.05M $34.28M
Selling and Admin Expenses $16.60M $13.40M $28.28M $11.35M $5.81M
-General & Admin Expense $16.60M $13.40M $28.28M $11.35M $5.81M
Research & Development $31.20M $33.40M $116.68M $32.89M $28.62M
Depreciation & Amortization & Depletion $3.50M $2.00M $7.73M $1.45M $2.62M
-Depreciation & Amortization $3.50M $2.00M $7.73M $1.45M $2.62M
Other Taxes -$700,000.00 -$900,000.00 -$5.64M -$645,000.00 -$2.77M
Operating Profit -$50.60M -$47.90M -$147.05M -$45.05M -$34.28M
Net Non-Operating Interest Income (Expense) $400,000.00 $500,000.00 $601,000.00 $597,000.00 $1.11M
Total Other Finance Costs -$400,000.00 -$500,000.00 -$601,000.00 -$597,000.00 -$1.11M
Pretax Profit -$50.20M -$47.40M -$146.46M -$44.46M -$33.16M
Tax $200,000.00 $200,000.00 $491,000.00 $374,000.00 $0.00
Net Profit -$50.40M -$47.60M -$146.95M -$44.83M -$33.16M
Profit from Continuing Operations -$50.40M -$47.60M -$146.95M -$44.83M -$33.16M
Net Income to Parent Company -$50.40M -$47.60M -$146.95M -$44.83M -$33.16M
Net Income to Common Stockholders -$50.40M -$47.60M -$146.95M -$44.83M -$33.16M
Basic EPS -$0.60 -$0.55 -$5.25 -$1.15 -$1.20
Diluted EPS -$0.60 -$0.55 -$5.25 -$1.15 -$1.20

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $223.20M $266.40M $233.72M $233.72M $110.50M
Total Current Assets $201.90M $246.70M $212.94M $212.94M $88.88M
Cash and Cash Equivalents & Short-Term Investments $174.90M $229.20M $194.17M $194.17M $69.84M
-Cash and Cash Equivalents $174.90M $229.20M $194.17M $194.17M $69.84M
Receivables $17.30M $15.10M $16.15M $16.15M $15.97M
-Taxes Receivable $14.70M $14.10M $14.57M $14.57M $14.65M
-Other Receivables $2.60M $1.00M $1.58M $1.58M $1.32M
Prepaid Assets $9.60M $2.40M $2.63M $2.63M $3.07M
Other Current Assets $100,000.00 – – – –
Total Non-Current Assets $21.30M $19.70M $20.78M $20.78M $21.61M
Net PPE $15.40M $14.10M $14.95M $14.95M $16.13M
-Gross PPE $38.90M $14.10M $37.82M $37.82M $16.13M
-Accumulated Depreciation -$23.50M – -$22.88M -$22.88M –
Non Current Accounts Receivables $600,000.00 – $620,000.00 $620,000.00 –
Non-Current Prepaid Assets $5.10M – – – –
Other Non-Current Assets $200,000.00 $5.50M -$1,000.00 -$1,000.00 $5.46M
Total Liabilities $62.80M $58.50M $64.95M $64.95M $57.64M
Total Current Liabilities $54.30M $51.80M $58.03M $58.03M $49.49M
Payables $12.40M $40.10M $41.53M $41.53M $39.96M
-Accounts Payable $11.80M $39.50M $40.94M $40.94M $39.82M
-Total Tax Payable $600,000.00 $600,000.00 $592,000.00 $592,000.00 $140,000.00
Current Accrued Expenses $27.60M – – – –
Short-Term Debt and Capital Lease Obligation $800,000.00 $1.00M $2.59M $2.59M $1.00M
-Current Capital Lease Obligation $800,000.00 $1.00M $1.12M $1.12M $1.00M
Other Current Liabilities $1.10M $1.00M $13.91M $13.91M $1.12M
Total Non-Current Liabilities $8.50M $6.70M $6.92M $6.92M $8.16M
Long Term Debt and Capital Lease Obligation $6.90M $5.10M $5.41M $5.41M $6.69M
-Long Term Capital Lease Obligation $6.90M $5.10M $5.41M $5.41M $6.69M
Other Non-Current Liabilities $1.60M $1.60M $1.51M $1.51M $1.47M
Total Equity $160.40M $207.90M $168.77M $168.77M $52.85M
Stockholders' Equity $160.50M $208.00M $168.77M $168.77M $52.85M
Capital Stock $34.00M $34.00M $26.91M $26.91M $15.39M
-Common Stock $34.00M $34.00M $26.91M $26.91M $15.39M
Additional Paid-In Capital $408.30M $625.60M $541.25M $541.25M $392.06M
Retained Earnings -$270.30M -$440.70M -$393.13M -$393.13M -$348.30M
Less: Treasury Stock $800,000.00 $1.00M $834,000.00 $834,000.00 $1.12M
Gains/Losses Not Affecting Retained Earnings -$10.70M -$9.90M -$5.43M -$5.43M -$5.18M
Goodwill and Other Intangible Assets – $100,000.00 $22,000.00 $22,000.00 $21,000.00
Investments and Advances – – $5.19M $5.19M –
-Available for Sale Securities – – $5.19M $5.19M –
-Current Debt – – $1.47M $1.47M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$52.60M -$49.10M -$121.18M -$35.17M -$32.41M
Net cash flow from continuing operations -$52.50M -$49.00M -$121.18M -$35.18M -$32.31M
Net Income from Continuing Operations -$50.40M -$47.60M -$146.95M -$44.83M -$33.12M
Depreciation & Depletion & Amortization $600,000.00 $900,000.00 $3.19M $690,000.00 $804,000.00
Other Non-Cash Items $0.00 -$100,000.00 -$217,000.00 -$1.23M -$87,000.00
Change in Working Capital -$9.10M -$7.60M $1.34M $6.14M -$4.20M
-Change in Inventory -$2.60M -$3.00M -$16.06M -$2.13M -$3.63M
-Change in Payables and Accrued Expense $100,000.00 -$500,000.00 $15.78M $1.50M -$617,000.00
-Change in Other Current Assets -$9.60M $600,000.00 -$4.70M $252,000.00 -$951,000.00
-Change in Other Current Liabilities $3.10M -$4.70M $6.52M $7.18M $841,000.00
Net cash flow from investing -$600,000.00 -$300,000.00 -$1.37M -$715,000.00 -$254,000.00
Net Cash Flow from Continuing Investing Activities -$700,000.00 -$200,000.00 -$1.37M -$714,000.00 -$255,000.00
Net PPE Purchase and Sale -$400,000.00 -$400,000.00 -$532,000.00 -$373,000.00 -$159,000.00
Financing Cash Flow $100,000.00 $88.90M $276.18M $159.06M $122,000.00
Net Cash Flow from Continuing Financing Activities $100,000.00 $88.90M $276.18M $159.06M $122,000.00
Net Common Stock Issuance $100,000.00 $88.90M $276.18M $159.06M $122,000.00
Ending Cash Balance $174.90M $229.20M $194.17M $194.17M $69.84M
Net Change in Cash -$53.20M $39.50M $153.63M $123.17M -$32.54M
Beginning Cash Balance $229.20M $194.20M $32.46M $69.84M $103.20M
Effect of Exchange Rate Changes -$1.10M -$4.50M $8.08M $1.16M -$779,000.00
Free Cash Flow -$53.00M -$49.50M -$121.72M -$35.55M -$32.57M
Net Intangibles Purchase and Sale – $0.00 -$6,000.00 – –
Net Other Investing Changes – $100,000.00 -$831,000.00 -$832,000.00 –
-Change In Other Working Capital – – -$203,000.00 -$660,000.00 $157,000.00
Net Investment Purchase and Sale – – – – -$96,000.00

Discussion

No comments yet — be the first to weigh in on DBVT.

Leave a comment

Scroll to Top